Home / Products / Respiratory Range / NILLE COLD
Click image to inspect pack details
Respiratory Range Marketed by Aerochem Neutron

NILLE COLD

Formulation Code AC-401
Commercial Status Active Product Information Available

Product Overview & Formulation Profile

Composition: Paracetamol 325mg + Phenylephrine 5mg + Guaiphenesin 50mg + Cetirizine HCl 5mg + Ambroxol HCl 15mg (tablets). It combines Paracetamol (analgesic and antipyretic), Phenylephrine (nasal decongestant), Guaiphenesin (expectorant), Cetirizine (second-generation antihistamine) and Ambroxol (mucolytic); each component acts on a different part of the clinical problem.

Paracetamol is an analgesic and antipyretic. Phenylephrine is an alpha-adrenergic agonist that relieves nasal congestion through vasoconstriction. Guaiphenesin is an expectorant that helps loosen bronchial secretions. Cetirizine is a second-generation H1-antihistamine. Ambroxol is a mucolytic that thins mucus and promotes its clearance.

NILLE-COLD is a prescription medicine from Aerochem Neutron's respiratory range, for use on the prescription of a registered medical practitioner.

Composition & Formulation Details

·       Contains Paracetamol 325mg + Phenylephrine 5mg + Guaiphenesin 50mg + Cetirizine HCl 5mg + Ambroxol HCl 15mg

·       Paracetamol — analgesic and antipyretic

·       Phenylephrine — alpha-adrenergic agonist that relieves nasal congestion through vasoconstriction

·       Guaiphenesin — expectorant that helps loosen bronchial secretions

·       Cetirizine — second-generation H1-antihistamine

·       Ambroxol — mucolytic that thins mucus and promotes its clearance

Presented as tablets

·       Common cold and flu with productive cough

·       Nasal congestion, sneezing and runny nose

·       Fever and body ache associated with cold

·       Note: indications reflect established uses of the individual molecules; confirm against the CDSCO-approved label for this fixed-dose combination

Safety

·       Contraindicated in patients with known hypersensitivity to any component.

·       Risk of hepatotoxicity with overdose or with other paracetamol-containing products; use caution in liver disease and chronic alcohol use.

·       Sympathomimetic decongestants should be used with caution in hypertension, heart disease, hyperthyroidism, diabetes and prostatic enlargement, and are contraindicated with MAO inhibitors.

·       May cause drowsiness; caution in renal impairment.

·       Rare severe cutaneous reactions have been reported; discontinue if rash develops.

·       Pregnancy and lactation: use only if the prescriber judges the benefit to outweigh the risk.

Clinical Rationale: The mechanisms and labelled uses of acetaminophen, phenylephrine, guaifenesin, cetirizine, ambroxol described here follow the US prescribing information (DailyMed). Use of the combination should follow the CDSCO-approved label for this fixed-dose combination.

References (Verified)

·       DailyMed (US NLM) prescribing information – acetaminophen: https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=ACETAMINOPHEN

·       DailyMed (US NLM) prescribing information – phenylephrine: https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=PHENYLEPHRINE

·       DailyMed (US NLM) prescribing information – guaifenesin: https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=GUAIFENESIN

·       DailyMed (US NLM) prescribing information – cetirizine: https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=CETIRIZINE

·       DailyMed (US NLM) prescribing information – ambroxol: https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=AMBROXOL

Professional Product Enquiries

Verified product information, formulation specifications, and commercial supply pathways for registered healthcare professionals, institutions, and trade partners.

Product Information

Review verified active composition, strength, dosage form, and packaging details on this page.

View Specifications

Healthcare Professional Enquiry

Request formulation literature, technical specifications, or product communication from our commercial team.

Submit Product Enquiry

Commercial Supply Enquiry

Connect regarding institutional supply requirements, trade distribution, or third-party contract manufacturing.

Commercial Enquiry

Professional Product Information

This product information is intended for registered healthcare professionals, medical practitioners, and authorized distribution partners. Product manufacturing is coordinated through eligible facility partners under applicable licences.

Product Enquiry

Request Formulation Details

Request information about NILLE COLD for professional use.

Please enter the numeric sum to verify you are a human visitor.
Therapeutic Alternatives

Related Formulations

Bilaero-M Formulation
Respiratory Range

Bilaero-M

View Formulation
TOSOUT SM Formulation
Respiratory Range

TOSOUT SM

View Formulation
TOSOUT LC Formulation
Respiratory Range

TOSOUT LC

View Formulation
TOSOUT D Formulation
Respiratory Range

TOSOUT D

View Formulation
Product Information

Need specifications for this formulation?

Request verified product information for professional use, or send a separate business enquiry for manufacturing or partnership discussions.

WhatsApp: +91 9512047000